It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cells utilise specialized polymerases from the Primase-Polymerase (Prim-Pol) superfamily to maintain genome stability. Prim-Pol’s function in genome maintenance pathways including replication, repair and damage tolerance. Mycobacteria contain multiple Prim-Pols required for lesion repair, including Prim-PolC that performs short gap repair synthesis during excision repair. To understand the molecular basis of Prim-PolC’s gap recognition and synthesis activities, we elucidated crystal structures of pre- and post-catalytic complexes bound to gapped DNA substrates. These intermediates explain its binding preference for short gaps and reveal a distinctive modus operandi called Synthesis-dependent Template Displacement (STD). This mechanism enables Prim-PolC to couple primer extension with template base dislocation, ensuring that the unpaired templating bases in the gap are ushered into the active site in an ordered manner. Insights provided by these structures establishes the molecular basis of Prim-PolC’s gap recognition and extension activities, while also illuminating the mechanisms of primer extension utilised by closely related Prim-Pols.
Mycobacteria Prim-PolC performs short gap synthesis following removal of lesions during excision repair. Here the authors resolve crystal structures of pre- and post-catalytic Prim-PolC complexes bound to gapped DNA substrates to define its mechanism.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 School of Life Sciences, University of Sussex, Genome Damage and Stability Centre, Brighton, UK (GRID:grid.12082.39) (ISNI:0000 0004 1936 7590); University of Brighton, School of Pharmacy and Biomolecular Sciences, Brighton, UK (GRID:grid.12477.37) (ISNI:0000000121073784)
2 School of Life Sciences, University of Sussex, Genome Damage and Stability Centre, Brighton, UK (GRID:grid.12082.39) (ISNI:0000 0004 1936 7590)
3 School of Life Sciences, University of Sussex, Genome Damage and Stability Centre, Brighton, UK (GRID:grid.12082.39) (ISNI:0000 0004 1936 7590); Polish Academy of Sciences, Institute of Medical Biology, Lodz, Poland (GRID:grid.413454.3) (ISNI:0000 0001 1958 0162)
4 School of Life Sciences, University of Sussex, Genome Damage and Stability Centre, Brighton, UK (GRID:grid.12082.39) (ISNI:0000 0004 1936 7590); BioClinicum, Karolinska University Hospital, Department of Oncology-Pathology, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705)
5 Polish Academy of Sciences, Institute of Medical Biology, Lodz, Poland (GRID:grid.413454.3) (ISNI:0000 0001 1958 0162)